Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas.

Rongcun, Y

Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Jul 1999 - 1037-44 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0022-1767


Carcinoma--genetics
Cell Separation
Colonic Neoplasms
Cytotoxicity Tests, Immunologic
Cytotoxicity, Immunologic
Epitopes, T-Lymphocyte--immunology
Female
HLA-A2 Antigen--biosynthesis
Humans
Lymphocyte Activation
Melanoma--genetics
Oligopeptides--chemical synthesis
Ovarian Neoplasms
Receptor, ErbB-2--biosynthesis
T-Lymphocytes, Cytotoxic--immunology
Tumor Cells, Cultured